https://www.selleckchem.com/products/adt-007.html
Introduction The risk of venous thromboembolism (VTE) increases during pregnancy and the puerperium such that VTE is a leading cause of maternal mortality. Methods We describe the clinical characteristics, diagnostic strategies, treatment patterns, and outcomes of women with pregnancy-associated VTE (PA-VTE) enrolled in the Global Anticoagulant Registry in the FIELD (GARFIELD)-VTE. Women of childbearing age ( less then 45 years) were stratified into those with PA-VTE ( n = 183), which included pregnant patients and those within the p
Like
Comment
Share
